iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Read More…
Basic Details
Issuer iShares
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBB
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A
Fund Focus
Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America
Fund Statistics
Assets Under Management$7.23 billion
Average Daily Volume$2.08 million
Discount/Premium-0.06%
ETF Expenses
Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%
Administrator, Advisor and Custodian
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions
What is iShares Nasdaq Biotechnology ETF's stock symbol?
iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."
How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?
iShares Nasdaq Biotechnology ETF declared a -- dividend on Tuesday, September 24th. Stockholders of record on Wednesday, September 25th will be paid a dividend of $0.0715 per share on Monday, September 30th. This represents a dividend yield of 0.1%. The ex-dividend date is Tuesday, September 24th. View iShares Nasdaq Biotechnology ETF's Dividend History.
When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?
iShares Nasdaq Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.
Has iShares Nasdaq Biotechnology ETF been receiving favorable news coverage?
Headlines about IBB stock have trended negative on Thursday, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a daily sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for iShares Nasdaq Biotechnology ETF.
Who are some of iShares Nasdaq Biotechnology ETF's key competitors?
Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Gabelli Equity Trust (GAB), Tri-Continental (TY), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), Tortoise Energy Infrastructure (TYG), PIMCO High Income Fund (PHK) and General American Investors (GAM).
What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?
Who are iShares Nasdaq Biotechnology ETF's key executives?
iShares Nasdaq Biotechnology ETF's management team includes the folowing people:
- George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
- Michael Arthur Latham, President, Trustee
- Jack Gee, Chief Financial Officer, Treasurer
- Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
- , Bio & Compensation -
- Amy Schioldager, Executive Vice President
- Ira P. Shapiro, Vice President, Chief Legal Officer
- Matt Tucker, Vice President
- , Bio & Compensation -
- Eilleen M. Clavere, Secretary
- Cecilia H. Herbert, Independent Trustee
- Charles A. Hurty, Independent Trustee
Who are iShares Nasdaq Biotechnology ETF's major shareholders?
iShares Nasdaq Biotechnology ETF's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Commerzbank Aktiengesellschaft FI (0.41%), Baltimore Washington Financial Advisors Inc. (0.10%), Neville Rodie & Shaw Inc. (0.09%), Toth Financial Advisory Corp (0.08%), Ferguson Wellman Capital Management Inc. (0.05%) and Osborn Williams & Donohoe LLC (0.05%).
Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?
IBB stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, CIBC Private Wealth Group LLC, Winfield Associates Inc., Ingalls & Snyder LLC, Vigilant Capital Management LLC, Ferguson Wellman Capital Management Inc., Toth Financial Advisory Corp and Baltimore Washington Financial Advisors Inc..
Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?
IBB stock was acquired by a variety of institutional investors in the last quarter, including Simplex Trading LLC, KG&L Capital Management LLC, KMG Fiduciary Partners LLC, Signaturefd LLC, North Star Investment Management Corp., Wiley BROS. Aintree Capital LLC, Founders Capital Management and Pennsylvania Trust Co.
How do I buy shares of iShares Nasdaq Biotechnology ETF?
Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is iShares Nasdaq Biotechnology ETF's stock price today?
One share of IBB stock can currently be purchased for approximately $103.05.
How big of a company is iShares Nasdaq Biotechnology ETF?
MarketBeat Community Rating for iShares Nasdaq Biotechnology ETF (NASDAQ IBB)
MarketBeat's community ratings are surveys of what our community members think about iShares Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe IBB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days.
